Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Recovering from chronic myeloid leukemia: the patients' perspective seen through the lens of narrative medicine.

Graffigna G, Cecchini I, Breccia M, Capochiani E, Della Seta R, Galimberti S, Melosi A, Simonetti F, Pizzuti M, Capalbo SF, Falzetti F, Mazza P, Di Renzo N, Mastrullo L, Rapezzi D, Orlandi E, Intermesoli T, Iurlo A, Pungolino E, Pacilli M.

Qual Life Res. 2017 Oct;26(10):2739-2754. doi: 10.1007/s11136-017-1611-8. Epub 2017 Jun 12.

PMID:
28608152
2.

Preference for subcutaneous or intravenous administration of rituximab among patients with untreated CD20+ diffuse large B-cell lymphoma or follicular lymphoma: results from a prospective, randomized, open-label, crossover study (PrefMab).

Rummel M, Kim TM, Aversa F, Brugger W, Capochiani E, Plenteda C, Re F, Trask P, Osborne S, Smith R, Grigg A.

Ann Oncol. 2017 Apr 1;28(4):836-842. doi: 10.1093/annonc/mdw685.

PMID:
28031173
3.

Personal history and quality of life in chronic myeloid leukemia patients: a cross-sectional study using narrative medicine and quantitative analysis.

Breccia M, Graffigna G, Galimberti S, Iurlo A, Pungolino E, Pizzuti M, Maggi A, Falzetti F, Capalbo SF, Intermesoli T, Maffioli M, Elena C, Melosi A, Simonetti F, Capochiani E, Seta RD, Pacilli M, Luppi M, Di Renzo N, Mastrullo L, Trabacchi E, Vallisa D, Rapezzi D, Orlandi EM, Gambacorti-Passerini C, Efficace F, Alimena G.

Support Care Cancer. 2016 Nov;24(11):4487-93. doi: 10.1007/s00520-016-3286-z. Epub 2016 Jun 3.

PMID:
27260015
4.

Prefmab: Final Analysis Of Patient Satisfaction With Subcutaneous Versus Intravenous Rituximab In Previously Untreated Cd20+ Diffuse Large B-Cell Lymphoma Or Follicular Lymphoma.

Rummel M, Kim TM, Plenteda C, Capochiani E, Mendoza M, Smith R, Osborne S, Grigg A.

Value Health. 2015 Nov;18(7):A469. doi: 10.1016/j.jval.2015.09.1237. Epub 2015 Oct 20. No abstract available.

5.

Preference for Rituximab Subcutaneous (Sc) and Intravenous (Iv) Among Patients With Cd20+ Non-Hodgkin's Lymphoma (Nhl) Completing the Rasq Measure In Randomized Phase Iii Studies Prefmab and Mabcute.

Rule S, Briones J, Smith R, Theodore OC, Ngoh CA, Osborne S, Capochiani E, Rummel M.

Value Health. 2014 Nov;17(7):A537. doi: 10.1016/j.jval.2014.08.1719. Epub 2014 Oct 26. No abstract available.

6.

Heart involvement in T cell lymphoma through hypereosinophilic syndrome: a common complication of a rare condition.

Genovesi-Ebert A, Lombardi M, Capochiani E, Simi U, Savoia MT, Baldini U, Digiorgio A, Carluccio M, Di Santo D, Galli M.

J Cardiovasc Magn Reson. 2005;7(2):495-9.

PMID:
15881534
7.

Impact of a new dosing regimen of epoetin alfa on quality of life and anemia in patients with low-risk myelodysplastic syndrome.

Spiriti MA, Latagliata R, Niscola P, Cortelezzi A, Francesconi M, Ferrari D, Volpe E, Clavio M, Grossi A, Reyes MT, Musto P, Mitra ME, Azzarà A, Pagnini D, D'Arena G, Spadano A, Balleari E, Pecorari P, Capochiani E, De Biasi E, Perego D, Monarca B, Pisani F, Scaramella G, Petti MC.

Ann Hematol. 2005 Mar;84(3):167-76. Epub 2004 Nov 30.

PMID:
15592833
8.

Lenograstim and filgrastim effects on neutrophil motility in patients undergoing chemotherapy: evaluation by computer-assisted image analysis.

Azzarà A, Carulli G, Rizzuti-Gullaci A, Capochiani E, Petrini M.

Am J Hematol. 2001 Apr;66(4):306-7. No abstract available.

9.

Paraneoplastic choreic syndrome during non-Hodgkin's lymphoma.

Nuti A, Ceravolo R, Salvetti S, Gambaccini G, Bonuccelli U, Capochiani E.

Mov Disord. 2000 Mar;15(2):350-2. No abstract available.

PMID:
10752595
10.

Interferon-alpha in the idiopathic hypereosinophilic syndrome: consideration of five cases.

Ceretelli S, Capochiani E, Petrini M.

Ann Hematol. 1998 Oct;77(4):161-4.

PMID:
9829847
11.

A new effective treatment for indolent lymphoma: a pilot study with fludarabine, idarubicin and prednisone combination (FLIDA).

Caracciolo F, Capochiani E, Papineschi F, Petrini M.

Hematol Oncol. 1997 Feb;15(1):27-31.

PMID:
9378469
13.

Motility of rhG-CSF-induced neutrophils in patients undergoing chemotherapy: evidence for inhibition detected by image analysis.

Azzarà A, Carulli G, Rizzuti-Gullaci A, Minnucci S, Capochiani E, Ambrogi F.

Br J Haematol. 1996 Jan;92(1):161-8.

PMID:
8562391
14.

Glutathione-S-transferase activity and multidrug resistance phenotype in chronic lymphocytic leukemia: do they have any clinical relevance?

Di Simone D, Testi R, Caracciolo F, Capochiani E, Ambrogi F, Grassi B, Petrini M.

Haematologica. 1995 Mar-Apr;80(2):103-7.

15.

Recombinant alpha 2a interferon and polycythemia vera: clinical results and biological evaluation by means of Fourier-transform infrared microspectroscopy.

Papineschi F, Bucalossi A, Capochiani E, Benedetti E, Bramanti E, Dastoli G, Dispensa E, Benedetti E, Spremolla G.

Eur J Haematol. 1994 Oct;53(4):213-7.

PMID:
7957805
16.

Hepatitis C virus infection in patients with non-Hodgkin's lymphoma.

Ferri C, Caracciolo F, Zignego AL, La Civita L, Monti M, Longombardo G, Lombardini F, Greco F, Capochiani E, Mazzoni A, et al.

Br J Haematol. 1994 Oct;88(2):392-4.

PMID:
7803287
17.

Alternating chemotherapy regimen (P-VABEC) for intermediate and high-grade non-Hodgkin's lymphoma of the middle aged and elderly.

Caracciolo F, Petrini M, Capochiani E, Papineschi F, Carulli G, Grassi B.

Hematol Oncol. 1994 Jul-Aug;12(4):185-92.

PMID:
7528162
18.

Third generation chemotherapy with P-VABEC for aggressive non-Hodgkin's lymphomas of the elderly.

Caracciolo F, Petrini M, Capochiani E, Papineschi F, Grassi B.

Leuk Lymphoma. 1993 Sep;11(1-2):115-8.

PMID:
8220144
19.

1,25-Dihydroxyvitamin D3 administration in a case of hairy cell leukemia.

Petrini M, Marchetti G, Cecconi N, Capochiani E, Ambrogi F, Grassi B.

Haematologica. 1990 Sep-Oct;75(5):491-2. No abstract available.

PMID:
2097275

Supplemental Content

Loading ...
Support Center